Crohn's Disease Clinical Trials in Rochester, New York

4 studies are recruiting for crohn's disease in Rochester, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

    Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from the anus, and belly pain. The main aim of this study is to check for how many participants with UC and CD signs and symptoms disappear after 3.5 month…

    Stage
    Phase 4
    Ages
    18 to 80
    Site
    Gastroenterology Group of Rochester, Rochester, New York
    Locations
    101 in total
    Run by
    Takeda

    See if you can join NCT06581328 on ClinicalTrials.gov

  2. A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

    Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. The purpose of this study is to evaluate the efficacy and safety of TAK-279 versus placebo in participants with moderately to severely active Crohn's disease (CD). The main aim of this study i…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Rochester Clinical Research, Rochester, New York
    Locations
    190 in total
    Run by
    Takeda

    See if you can join NCT06233461 on ClinicalTrials.gov

  3. A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

    The study is an extension of two parent studies (MLN0002-3024 [NCT04779307] and MLN0002-3025 [NCT04779320]). Participants must have participated in one of the previous studies. The purpose of this study is to collect the long-term safety of vedolizumab in children with UC or CD.

    Stage
    Phase 3
    Ages
    2 and older
    Site
    University of Rochester Medical Center - PPDS, Rochester, New York
    Locations
    98 in total
    Run by
    Takeda

    See if you can join NCT05442567 on ClinicalTrials.gov

  4. A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

    This is a Phase 2, multicenter, platform study in adult participants with IBD (moderately to severely active Crohn's Disease or Ulcerative Colitis). The primary goal of this study is to assess the safety and efficacy of multiple investigational drugs.

    Stage
    Phase 2
    Ages
    18 to 80
    Site
    Mirador Therapeutics Selected Site, Rochester, New York
    Locations
    66 in total
    Run by
    Mirador Therapeutics, Inc.

    See if you can join NCT07113522 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.